Scopi Medical

Scopi’s CEO to attend JP Morgan Chase Conference.

We’re designing portable, smarter medical visualization technology for care providers.

Recent Accomplishments:

Learn more from Scopi CEO & Chief Engineer Anna Von Wendorff on the TWIST of FATE PODCAST

Scopi wins Top Prize at Sacramento State’s 4th Annual Spark Venture Competition

Scopi acknowledged in 2022 FourthWave Cohort dedicated to Female Entrepreneurship

Scopi featured in Extreme Design for Extreme Affordability Article sponsored by Stanford Business & Engineering

Testimonials

“Air Force medical students and/or residents are trained to provide primary care for a variety of Nasal cavity or Lumen complications. The potential for Scopi in our line of work could introduce a new standard of care.”

Air Force Researcher

“Scopi is evaluating contemporary human-centric medical device design to deliver a portable, accessible visualization tool to redefine primary care.”

Usability Researcher

“In a time of great uncertainty post-COVID, an investment in Scopi is a safe pathway to a future of better healthcare for all powered by Machine Learning and Artificial Intelligence.

Investor

Our Partners

Scopi’s Mission

At Scopi, we envision a future where endoscopy is ubiquitous. Scopi's innovative approach makes medical visualization easier, faster, and more accessible, potentially enabling physicians to confidently diagnose Ear Nose Throat (ENT) conditions more accurately.

We are a mission-driven Health Tech startup leveraging Machine Learning and Artificial Intelligence dedicated to providing next-generation endoscopic solutions that enable any clinic, no matter how small or remote, to provide the highest quality care possible.

Endoscopy Visualization, Anywhere

With Scopi’s groundbreaking research, detailed imaging could happen virtually anywhere. Our suite of proprietary software will support real-time data interpretation, using machine learning and AI to get physicians accurate insights swiftly.

The Problem…

400M

patients worldwide

Source: Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63:(suppl. 86):8–160, 2008

Though traditional endoscopes could diagnose the root cause behind patient complications, these large and expensive machines are not economically scaleable for accessibility. The result? Of the patients with chronic sinusitis as a primary diagnosis, there are:

91%

of patients are undiagnosed or misdiagnosed

Source: Novis, Sarah J., et al. "A diagnostic dilemma: chronic sinusitis diagnosed by non‐otolaryngologists." International forum of allergy & rhinology. Vol. 6. No. 5. 2016.

As doctors struggle to determine differential diagnoses, patients may get caught in unnecessary office visits and could experience complications with potential readmission that span weeks or even months. Doctors grow frustrated, patients lose time, and healthcare costs balloon, with billions spent on incorrect nasal and sinus treatments.

Scopi Is The Solution

We’re pairing cutting-edge, mobile hardware with an AI-supported software suite that supports clinicians with reliable, rapid data interpretation that delivers diagnostic confidence and accuracy.

Scopi’s Innovative Approach

Functional Value

  • Ease of Use & Reliability: Scopi is working to provide online & digital education to PCPs, as well as nasal visualization solutions that could be biocompatible for aseptic technique
  • Portability: Scopi is developing affordable handheld endoscopy designs portable for bedside examination
  • Multi-Use: Scopi is creating affordable technology with extended design life

Monetary Value

  • Health Economics: Scopi is exploring practice management and workflow integration for value-based care
  • Payers: Scopi is developing medical device solutions to aid in reducing hospital readmission and lowering the cost of care

Social Value

  • Quality of Life: Scopi is creating innovative tools to aid diagnostic decision-making by ENT specialists
  • Aging Population: Scopi’s endoscopy procedures may reduce undiagnosed nasal and sinus infections
  • Working Force: Scopi’s transformative technology may reduce days out of work associated with undiagnosed ENT symptoms & complications

Clinical Value

  • Setup & Tear down: Scopi’s portable endoscopic technology will not significantly impact routine clinical medicine or workflow
  • Exam Time: Scopi’s visualizations will integrate into routine bedside examination

Psychological Value

  • Diagnostic Confidence: Scopi is undergoing clinical evaluation and research to demonstrate improvement in diagnostic accuracy for specific ENT complications and symptoms
  • Diagnostic Certainty: Scopi is exploring clinical collaborations and partnerships to demonstrate improvement in patient satisfaction living with the effects of ENT complications

Our Team

Anna von Wendorff

CEO

Dr. Michael Wong, MD

CMO

Douglas Younger

Marketing, Sales and Service

David Hawks

Strategy and Operations

Steven Kent

Advisor to CEO

Jessie Becker Alexander

Strategy

Staci Miller

Human Factors UX

John Sheets, PhD

Medical Device Expert

Rohan Natraj

Voice of Customer

Dr. Mike Wilson, MD

Clinical

Theresa Kimler

Technical Project Management